Stay updated on Intranasal Etripamil Safety Study for PSVT Clinical Trial
Sign up to get notified when there's something new on the Intranasal Etripamil Safety Study for PSVT Clinical Trial page.

Latest updates to the Intranasal Etripamil Safety Study for PSVT Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedA new Revision: v3.4.2 is displayed; the government-funding notice and the prior Revision: v3.4.1 notice were removed.SummaryDifference0.3%

- Check49 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center’s operating status with a link to opm.gov for updates. Updated the page version to Revision: v3.4.1, replacing the previous v3.4.0.SummaryDifference0.3%

- Check56 days agoChange DetectedUI/metadata updates include Show glossary, the label Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, with corresponding removal of Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check70 days agoChange DetectedRevision: v3.3.4 now appears on the page, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

- Check92 days agoChange DetectedLocations section expanded to include sites across multiple US states and Canadian provinces. Revision updated from v3.3.2 to v3.3.3.SummaryDifference2%

Stay in the know with updates to Intranasal Etripamil Safety Study for PSVT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Etripamil Safety Study for PSVT Clinical Trial page.